U.S. consumers tell insurers to cover experimental drugs

By Matt Stroud
January 24, 2012

[IMGCAP(1)] NEW YORK | Mon Jan 23, 2012 9:42am EST (Reuters) - When your health insurance provider denies an experimental treatment or a high-cost drug, how much are you willing to pay for the care you believe you need? Barby Ingle, a former cheerleading and dance coach at Washington University who now lives in a Phoenix suburb, has been forced to face this question. …

Get access to this article and thousands more...

All Employee Benefit Adviser articles are archived after seven days. REGISTER NOW for unlimited access to all recently archived articles, as well as thousands of searchable stories. Registered Members also gain access to exclusive industry white paper downloads, web seminars, podcasts and blog discussions. Members may also choose to receive any of our daily or weekly e-newsletters covering the latest breaking news, opinions from industry leaders and developing trends with specialized topics like defined contribution/defined benefit, healthcare insurance news, voluntary benefits, and legal issues.

Already Registered?

Get our daily e-newsletter, unlimited access to 2,500+ in-depth articles plus other exclusive benefits specifically for benefit brokers and advisers - Register Today

Related Articles

Most Popular

Most Forwarded